---
title: "600572.SH (600572.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600572.SH/news.md"
symbol: "600572.SH"
name: "600572.SH"
parent: "https://longbridge.com/en/quote/600572.SH.md"
datetime: "2026-05-21T02:35:45.114Z"
locales:
  - [en](https://longbridge.com/en/quote/600572.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600572.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600572.SH/news.md)
---

# 600572.SH (600572.SH) — Related News

### [Multinational giants gather at the "Biopharmaceutical Industry Valley," with capital pouring into cell therapy and brain-computer interface new technologies](https://longbridge.com/en/news/285736000.md)
*2026-05-08T13:33:11.000Z*
> At the 2026 Taihu Bay Life and Health Future Conference, several multinational medical companies reiterated their commit

### [CONBA's subsidiary Bunan Selin Tablets has obtained a drug registration certificate](https://longbridge.com/en/news/285694822.md)
*2026-05-08T09:08:05.000Z*
> CONBA's wholly-owned subsidiary, Zhejiang Jinhua CONBA Biopharmaceutical Co., Ltd., recently obtained the Drug Registrat

### [CONBA: Zhen Shi Ming has completed the work on the shareholding system transformation and will choose an appropriate time to initiate the IPO-related work](https://longbridge.com/en/news/284176714.md)
*2026-04-27T08:29:42.000Z*
> On April 27th, CONBA stated on the interactive platform that the current operating situation of Zhenzhi Ming Company is 

### [CONBA: Net profit in the first quarter of 2026 was 198 million yuan, a year-on-year increase of 4.78%](https://longbridge.com/en/news/283650951.md)
*2026-04-22T11:09:11.000Z*
> CONBA announced that in the first quarter of 2026, operating revenue was 1.906 billion yuan, a year-on-year increase of 

### [Afternoon volatility! 600572, vertical limit up! Main funds flow into the pharmaceutical sector](https://longbridge.com/en/news/282814798.md)
*2026-04-15T09:12:34.000Z*
> The pharmaceutical and biotechnology, power grid equipment, newly listed stocks, and aquaculture sectors led the gains. 

### [](https://longbridge.com/en/news/282773359.md)
*2026-04-15T02:40:37.000Z*
> A-shares of innovative drugs strengthened, Huaren Health approached a 20% limit-up, Realcan, HISUN, JINLING PHARM., and 

### [CONBA's subsidiary has obtained a drug registration certificate for Telmisartan and Amlodipine Tablets (II)](https://longbridge.com/en/news/282172004.md)
*2026-04-09T10:03:03.000Z*
> CONBA's wholly-owned subsidiary Hangzhou CONBA Pharmaceutical Co., Ltd. has recently obtained the Drug Registration Cert

### [Tmall Health has joined dozens of brands to establish the "Health Supplement Assurance Alliance"](https://longbridge.com/en/news/281623439.md)
*2026-04-03T09:29:57.000Z*
> On April 3rd, Tmall Health, in collaboration with dozens of well-known domestic health supplement companies such as By-H